Our purpose is to connect every African patient to quality healthcare, every day

Our unique
value proposition

With Africa at the heart of our strategy, we build commercial solutions that give our principals access to customers, patients, and consumers through comprehensive route to market and channel strategies, integrated with sourcing and procurement, demand generation, distribution, and marketing. Our extensive experience in navigating the complex African continent and proven success in developing and implementing market access solutions and value-add logistics, positions Imperial as a strategic partner to clients and principals wanting to enter and grow in emerging and challenging economies.

We provide the opportunity for our principals to trade in a de-risked environment as we are able to assume responsibility for forex, debtor’s and stock write-off risk.


As the leading healthcare distributor in East, West and Southern Africa, we boast the broadest warehousing and distribution capacity serving healthcare markets in Sub Saharan Africa.

Through our operations, we can provide market access services in more than 20 countries on the African continent. Over the short and medium term, we plan to expand our footprint into new regions, including Francophone and North Africa, and to leverage our expertise in other key industries.

Where do we operate today?


Our market access solutions see us taking ownership of inventory and responsibility for the full order to cash function. We provide an end-to-end solution to manufacturers focused on simplification of the operating model, sustainable growth, and compliance.

Our services across the healthcare value chain include integrated commercial solutions comprising logistics, healthcare distributorships, multi-market aggregation, sourcing and procurement, emergency relief and kitting, contract manufacturing as well as marketing and promotion services.

We leverage our significant logistics and distribution platforms on the African continent, with established distribution leadership positions in key markets such Nigeria and Kenya to provide unparalleled coverage and market access.

How we
help you

We take ownership of inventory and responsibility for the full order to cash function

  • Our solutions leverage our freight and contract logistics capabilities
  • We operate to the highest quality and compliance standards
  • We have access to multiple African markets
  • We minimise the risk of trading in Africa
  • As early adopters of new technology, we deliver end-to-end solutions that enable customer transparency and improve operational efficiency

Driving patients' access
to affordable, quality assured medicines

Imperial’s integrated master distribution solution aggregates subscale markets into a single agreement while combining other essential capabilities to offer principals a simplified operating model on the African continent reducing operational demands, risk and complexity without sacrificing growth or service quality.

We offer in-market regulatory
and medical governance

Imperial not only has proven technology capability, but also a deep understanding of regulatory and pharmacovigilance, ensuring that we offer flexible options to manage local and central product safety requirements. We have a tested hub-model, multi-lingual competent staff and all our platforms for regulatory, PV & EDC conform to the FDA 21 CFR Part 11 standards.


  • has experience of the African market and understands its unique requirements
  • is highly proficient in managing unpredictable currency exposures, unexpected costs and evolving exchange control regulations
  • gives brand owners informed access to consumers through our extensive in-country networks
  • offers well tested and co-ordinated strategies for managing governance and corporate compliance
  • is highly experienced in navigating international political, legal or system risk and numerous trade barriers in day-to-day business operations.

Market Access Healthcare
Leadership team

David Pritchard

Executive Vice President: Market Access | Healthcare

Responsible for redefining the global strategy in Healthcare at Imperial, building on the company infrastructure in Africa. The Market Access Healthcare business generates approx. $500 million in revenue and is growing at approx. 20%. Member of the Market Access Executive Committee . EVP with 30 years of broad, solid commercial pharmaceutical experience and a history of delivering outstanding success in both developed and Emerging Market settings. David worked for Glaxo Smith Kline (GSK) for almost 30 years in various roles with the most recent being Vice President and Head of Africa and Developing Countries Asia. As a member of the Executive Committee of ViiV Healthcare, a GSK company, delivered world leading launches of novel antiretrovirals securing commercial success for its new portfolio.

Emile Malan

Advisor: Market Access | Healthcare

Leads an emerging integrated pharmaceutical services provider founded in 2018, providing regulatory services to Imperial. Experienced pharmaceutical executive with 10+ years of international and African medical, regulatory and commercial experience (Pfizer UK, GSK Africa and Asia developing countries) including creation of medical affairs service hubs providing content approval, medical information and pharmacovigilance services. Experienced clinician with 8+ years in hospital and primary care. Therapeutic expertise include: Vaccines, Inflammation/Immunology, Infectious Disease (incl. HIV, TB), Diabetes, Cardiovascular, CNS, other major NCDs (Respiratory, Oncology etc.).

Chris Oosthuizen

Vice President: Commercial Solutions | Market Access | Healthcare

Responsible for commercial management of new and existing partnerships. Senior Executive with extensive experience in pharmaceutical & vaccines commercial business across Africa including institutional business. Roles held include Commercial Excellence Director for Africa & Developing Countries (GSK), Head of Marketing & Access and Senior Manager Supranational Affairs for GSK Global Vaccines. During his 7-year tenure at GSK, Chris led the vaccines team at GSK that successfully implemented 7 Rotavirus & 3 Pneumococcal vaccine introductions into the national vaccination programs of countries in sub-Saharan Africa while also securing demonstration projects for Human Papilloma Virus in 3 markets. Having started his career as a sales representative and combined with his management experience, it provides Chris with in-depth knowledge and understanding of pharmaceuticals sales and marketing and what it takes to be successful.

Graham Wilson

Vice President: Healthcare Services | Market Access | Healthcare

Responsible for strategy execution, in-market activities and sales team effectiveness. Senior Executive with 22 years’ experience in pharmaceutical, nutritional and consumer healthcare businesses gained in Europe as well as across Africa. Roles held include Business Development Manager for Africa (Abbott), National Sales Manager South Africa (Abbott & Sandoz), Commercial Manager UK (Novartis Consumer), NHS liaison Manager (Novartis). Having started his career as a sales representative and progressing into various managements roles responsible for sales teams in many multinational pharmaceutical companies, with in-depth knowledge and understanding of Sub-Saharan African markets, Graham and his team bring their extensive experience to ensure success and growth for new principals in Africa.

Craig Wilson

Senior Vice President: Finance | Market Access | Healthcare

Responsible for the Financial management of Market access Healthcare in Africa. Experienced financial executive with 12+ experience in the Pharmaceutical, Consumer Health and vaccines commercial business across Africa. Craig is a Chartered Accountant and his roles held were Financial director GSK Africa & developing countries, Novartis Consumer Health Africa, and Reckitt Benckiser.

Enquire now